Integrium to chair session at magi west
INTEGRIUM TO CHAIR SESSION AT MAGI WEST
Tustin, Calif. – Marketwire - October 13, 2010 – Integrium LLC, a Contract Research Organization (CRO) specializing in cardiovascular and metabolic disease clinical research, today announced that its Director of Project Management and Field Operations Liza Moore will participate in MAGI's Clinical Research Conference West to be held October 24-27 at The Fairmont San Francisco. Ms. Moore will moderate a discussion titled "Just CROs: Challenges and Solutions" on Monday, October 25 at 4:45 p.m.
Leveraging her extensive, 13 year study experience and firsthand knowledge of a wide variety of sites, Ms. Moore will help drive a discussion centered on what's needed for success today as well as shared insights on lessons learned. Before joining Integrium, Ms. Moore held senior clinical trial manager roles at Omnicare Clinical Research, Alteon and Ortec International. Ms. Moore spent the earlier part of her career as an ICU senior staff nurse at New York University Medical Center in New York, New York.
Specialty CROs like Integrium are well-positioned to meet the demands and requirements of leading sponsors due to expertise in driving efficiencies during the patient enrollment phase. Integrium has differentiated itself by demonstrating a deep understanding of the complexities and nuances of clinical research in three core therapeutic areas -- cardiovascular disease, metabolic disease and dermatology -- and by delivering successful clinical study solutions to biopharmaceutical companies.
MAGI's (Model Agreements & Guidelines International) Clinical Research Conference hosts more than 90 sessions and workshops and offers practical tips in a comprehensive program for operations, regulatory, contracts and budgets. For more information and to see the full agenda, click here: www.magiworld.org/events/2010W/.
About Integrium, LLC
Integrium is a therapeutically-focused, full-service contract research organization that specializes in dermatology, cardiovascular and metabolic clinical research. It has a strong reputation for delivering high-quality management of global clinical development programs and service to its clients. Combining the Integrium Clinical Excellence (ICE) study start-up and management methodology, and therapeutic expertise leads sponsors to more confident, better-informed drug and device development decisions. For more information please visit www.integrium.com.